A LinkedIn post from BrowserStack highlights how healthcare-focused Twin Health reportedly increased test automation coverage from 0 to 60% in three months using BrowserStack’s low-code automation platform. The post also suggests test authoring time was reduced by 75% after moving away from a code-heavy Appium and Selenium setup.
According to the post, the AI-enabled platform allowed both manual testers and engineers to create, run, and debug tests on real Android and iOS devices from a single environment without additional infrastructure. The content further notes claimed reductions of 60% in debugging time and a shift toward team-wide ownership of software quality.
For investors, the case study-style post underscores BrowserStack’s push into low-code, AI-powered test automation as a way to broaden its user base beyond traditional developers. If such outcomes are representative across customers, they could support higher platform stickiness, expansion revenue, and competitive positioning against legacy testing tools.
The emphasis on real-device testing and faster coverage for high-priority user flows may be particularly relevant in regulated and reliability-sensitive sectors like digital health. This positioning could help BrowserStack capture more enterprise contracts, potentially improving long-term growth prospects and reinforcing its role in the quality assurance tooling ecosystem.